Skip to content

Treatment of Fibromyalgia and CFS With Ribose, Ashwagandha, Rhodiola, Licorice, Schisandra and Green Tea Extract

Treatment of Fibromyalgia and CFS With Ribose, Ashwagandha, Rhodiola, Licorice, Schisandra and Green Tea Extract

Status
UNKNOWN
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04598243
Enrollment
70
Registered
2020-10-22
Start date
2020-10-14
Completion date
2021-07-04
Last updated
2020-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CFS, Fibromyalgia

Brief summary

Is a combination of Ribose, Ashwagandha, Rhodiola, Schisandra, licorice, and green tea extract helpful in CFS and FIbromyalgia?

Detailed description

Ribose has been shown to be very helpful in CFS and fibromyalgia. Many studies have also shown benefit for the symptoms of these conditions from Ashwagandha, Rhodiola, Schisandra, licorice, and green tea extract. The study is undertaken as an early open label study to check for the efficacy of a proprietary combination of these

Interventions

DIETARY_SUPPLEMENTSmart Energy System

A nutritional /herbal combination

Sponsors

Practitioners Alliance Network
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. be diagnosed with CFS and/or fibromyalgia 2. live in the United States 3 - be over 18 years of age

Exclusion criteria

1. pregnancy 2. Diabetes 3. Hypertension

Design outcomes

Primary

MeasureTime frameDescription
VAS4-6 weeksA composite VAS of Fatigue, Pain, Sleep, Cognition and overall well-being. These are each on a 1-10 scale with the same units, with 10 being healthy. The composite sum total of all of these (0-50) will be used as a single outcome measure

Countries

United States

Contacts

Primary ContactJacob Teitelbaum, MD
FatigueDoc@gmail.com4105627409

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026